Stryker Corporation
(SYK) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
352.27
-2.52%
After-hours Jan 06, 2025, 07:29 PM EST
Stryker Corporation Revenue Breakdown
Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MedSurg Revenue | 3.22B | 3.12B | 3.00B | 3.43B | 2.86B | 2.86B | 2.69B | 3.05B | 2.59B | 2.55B | 2.42B | 4.41B | 1.75B | 1.75B | 1.62B | 1.85B | 1.60B | 1.32B | 1.62B | 1.84B | 1.58B | 1.62B | 1.54B | 1.72B | 1.44B | 1.46B | 1.43B | 1.58B | 1.34B | 1.34B | 1.30B | 1.43B | 1.25B | 1.26B | 958.00M | 1.09B | 943.00M | 939.00M | 927.00M | 1.05B | 936.00M | 905.00M | 886.00M | 924.00M | 792.00M | 819.00M | 824.00M | 877.00M | 781.00M | 786.00M | 821.00M | 2.39B | 766.00M |
MedSurg Revenue Growth | +3.43% | +3.93% | -12.49% | +19.87% | -0.03% | +6.32% | -11.83% | +17.89% | +1.53% | +5.20% | -45.11% | +151.51% | +0.40% | +7.83% | -12.57% | +15.88% | +20.85% | -18.37% | -11.70% | +16.56% | -2.54% | +4.73% | -10.23% | +19.20% | -0.82% | +1.96% | -9.68% | +18.26% | 0.00% | +2.38% | -8.42% | +13.73% | -0.40% | +31.32% | -11.79% | +15.16% | +0.43% | +1.29% | -12.05% | +12.61% | +3.43% | +2.14% | -4.11% | +16.67% | -3.30% | -0.61% | -6.04% | +12.29% | -0.64% | -4.26% | -65.71% | +212.53% | n/a |
Orthopaedics and Spine Revenue | 2.27B | 2.31B | 2.24B | 2.39B | 2.05B | 2.14B | 2.09B | 2.15B | 1.89B | 1.94B | 1.85B | 4.93B | 876.00M | 918.00M | 848.00M | 882.00M | 820.00M | 546.00M | 744.00M | 827.00M | 749.00M | 760.00M | 722.00M | 700.00M | 628.00M | 639.00M | 598.00M | 586.00M | 538.00M | 535.00M | 515.00M | 526.00M | 503.00M | 500.00M | 480.00M | 483.00M | 458.00M | 458.00M | 429.00M | 454.00M | 437.00M | 430.00M | 420.00M | 437.00M | 410.00M | 414.00M | 397.00M | 414.00M | 380.00M | 393.00M | 382.00M | 1.07B | 363.00M |
Orthopaedics and Spine Revenue Growth | -1.52% | +2.72% | -6.03% | +16.49% | -4.03% | +2.30% | -2.93% | +13.75% | -2.73% | +4.97% | -62.42% | +462.56% | -4.58% | +8.25% | -3.85% | +7.56% | +50.18% | -26.61% | -10.04% | +10.41% | -1.45% | +5.26% | +3.14% | +11.46% | -1.72% | +6.86% | +2.05% | +8.92% | +0.56% | +3.88% | -2.09% | +4.57% | +0.60% | +4.17% | -0.62% | +5.46% | 0.00% | +6.76% | -5.51% | +3.89% | +1.63% | +2.38% | -3.89% | +6.59% | -0.97% | +4.28% | -4.11% | +8.95% | -3.31% | +2.88% | -64.43% | +195.87% | n/a |
Revenue by Geography
Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asia Pacific Revenue | 1.95B | 1.89B | 1.97B | 1.63B | 1.62B | 1.53B | 1.41B | 1.31B | 1.25B | 1.37B | 1.32B | 1.34B | 1.66B |
Asia Pacific Revenue Growth | +3.24% | -4.46% | +21.04% | +0.80% | +5.55% | +8.42% | +7.53% | +5.04% | -8.55% | +3.71% | -1.27% | -19.32% | n/a |
Emea Revenue | 2.62B | 2.35B | 2.30B | 1.82B | 1.89B | 1.79B | 1.57B | 1.44B | 1.27B | 1.37B | 1.32B | 1.27B | n/a |
Emea Revenue Growth | +11.50% | +2.13% | +26.46% | -3.71% | +5.30% | +14.42% | +8.67% | +13.81% | -7.59% | +4.18% | +3.95% | n/a | n/a |
Other Foreign Countries Revenue | 677.00M | 578.00M | 515.00M | 448.00M | 422.00M | 428.00M | 405.00M | 322.00M | 312.00M | 378.00M | 402.00M | 397.00M | n/a |
Other Foreign Countries Revenue Growth | +17.13% | +12.23% | +14.96% | +6.16% | -1.40% | +5.68% | +25.78% | +3.21% | -17.46% | -5.97% | +1.26% | n/a | n/a |
Operating Expense Breakdown
Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 1.90B | 1.81B | 1.84B | 1.94B | 1.70B | 1.71B | 1.78B | 1.75B | 1.46B | 1.54B | 1.71B | 1.75B | 1.60B | 1.50B | 1.57B | 1.56B | 1.24B | 1.23B | 1.33B | 1.38B | 1.29B | 1.28B | 1.40B | 1.43B | 1.24B | 1.19B | 1.24B | 1.22B | 1.10B | 1.13B | 1.10B | 1.09B | 1.06B | 1.04B | 944.00M | 970.00M | 887.00M | 861.00M | 892.00M |
Selling, General, and Administrative Revenue Growth | +4.52% | -1.41% | -5.20% | +14.11% | -0.29% | -4.21% | +1.71% | +20.34% | -5.46% | -10.00% | -2.01% | +8.93% | +6.45% | -4.44% | +0.83% | +25.56% | +1.55% | -7.89% | -3.62% | +6.89% | +0.70% | -8.62% | -1.96% | +15.22% | +4.37% | -3.72% | +1.56% | +10.34% | -2.39% | +2.54% | +0.82% | +3.41% | +1.34% | +10.49% | -2.68% | +9.36% | +3.02% | -3.48% | n/a |
Research and Development Revenue | 377.00M | 352.00M | 368.00M | 350.00M | 353.00M | 346.00M | 339.00M | 326.00M | 364.00M | 351.00M | 413.00M | 331.00M | 306.00M | 310.00M | 288.00M | 255.00M | 242.00M | 233.00M | 254.00M | 254.00M | 246.00M | 246.00M | 225.00M | 221.00M | 221.00M | 216.00M | 204.00M | 205.00M | 198.00M | 192.00M | 192.00M | 189.00M | 184.00M | 183.00M | 159.00M | 164.00M | 155.00M | 154.00M | 152.00M |
Research and Development Revenue Growth | +7.10% | -4.35% | +5.14% | -0.85% | +2.02% | +2.06% | +3.99% | -10.44% | +3.70% | -15.01% | +24.77% | +8.17% | -1.29% | +7.64% | +12.94% | +5.37% | +3.86% | -8.27% | n/a | +3.25% | n/a | +9.33% | +1.81% | n/a | +2.31% | +5.88% | -0.49% | +3.54% | +3.12% | n/a | +1.59% | +2.72% | +0.55% | +15.09% | -3.05% | +5.81% | +0.65% | +1.32% | n/a |